$CELZ- The Russia PromoMed deal will catapult the global growth. Looking forward to their follow-up on the 2 patients treated with CAVERSTEM in October. If results from those patients are as expected, things will begin to move quickly. And if the Minister of Urology gets insurance to cover a strong portion or all of the procedure, well then the millions of men suffering from ED in Russia will be running to get the treatment done.
I expect CMTH/CELZ revenue to really take off in 2019 and have 5M shares holding until at least May to see the revenue progression.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.